Bacillus sonorensis L. Asparaginase: Cloning, Expression in E. coli and Characterization

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• L-asparaginases (L-ASNases) are crucial enzymes in cancer therapy, particularly for acute lymphoblastic leukemia.
• The need for novel L-ASNases with improved properties drives research into microbial sources.

Purpose of the Study:

• To isolate and characterize a novel L-asparaginase from Bacillus sonorensis.
• To evaluate its potential as a therapeutic agent for blood cancers.

Main Methods:

• Isolation of the L-ASNase gene from Bacillus sonorensis using PCR.
• Cloning and expression of the gene in Escherichia coli.
• Purification of the recombinant enzyme via affinity chromatography.
• Characterization of enzyme activity, stability, and substrate specificity.

Main Results:

• A 36 kDa L-ASNase was successfully expressed and purified.
• The enzyme demonstrated optimal activity at 45°C and pH 7.0.
• High thermostability was observed, retaining significant activity after incubation at elevated temperatures.
• The enzyme exhibited specific activity towards L-asparagine with minimal glutaminase activity.

Conclusions:

• The characterized Bacillus sonorensis L-ASNase is a promising candidate for further development in cancer treatment.
• Its specific activity and stability suggest potential advantages over existing therapies.